Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders ...

The timely Viral Vector Formulation and Process Development Summit Europe is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, ...

Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites. Avid Bioservices, a biologics-focused contract ...

Effective process development for viral vector-based medicines is paramount for optimized process efficiency, robustness, scalability, and product quality. Well-designed processes streamline ...

Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...

Adeno-associated virus (AAV) has emerged as a leading platform for gene delivery for treating various diseases due to its excellent safety profile and efficient transduction to various target tissues.